Veeva Systems Inc. (NYSE:VEEV) Shares Purchased by TFB Advisors LLC

TFB Advisors LLC raised its stake in Veeva Systems Inc. (NYSE:VEEV) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,542 shares of the technology company’s stock after purchasing an additional 84 shares during the period. TFB Advisors LLC’s holdings in Veeva Systems were worth $745,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of VEEV. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Veeva Systems by 72.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Veeva Systems during the third quarter worth about $26,000. True Wealth Design LLC raised its position in shares of Veeva Systems by 3,375.0% in the third quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after buying an additional 135 shares during the last quarter. Retirement Wealth Solutions LLC acquired a new position in shares of Veeva Systems in the fourth quarter valued at approximately $31,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in Veeva Systems in the third quarter valued at approximately $49,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

Insider Buying and Selling at Veeva Systems

In related news, SVP Jonathan Faddis sold 1,694 shares of Veeva Systems stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $230.30, for a total value of $390,128.20. Following the transaction, the senior vice president now directly owns 8,061 shares in the company, valued at $1,856,448.30. This trade represents a 17.37 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 10.50% of the company’s stock.

Veeva Systems Stock Down 1.4 %

Shares of NYSE VEEV opened at $234.43 on Wednesday. Veeva Systems Inc. has a 52-week low of $170.25 and a 52-week high of $258.93. The firm has a market cap of $38.06 billion, a price-to-earnings ratio of 57.88, a price-to-earnings-growth ratio of 1.97 and a beta of 0.85. The company’s 50-day simple moving average is $224.68 and its 200-day simple moving average is $215.12.

Analyst Ratings Changes

Several brokerages have recently weighed in on VEEV. Evercore ISI upped their target price on shares of Veeva Systems from $220.00 to $245.00 and gave the company an “in-line” rating in a research note on Friday, December 6th. Scotiabank lifted their target price on Veeva Systems from $235.00 to $240.00 and gave the company a “sector perform” rating in a research note on Friday, December 6th. StockNews.com downgraded Veeva Systems from a “buy” rating to a “hold” rating in a research note on Thursday, February 6th. Stifel Nicolaus raised their price objective on shares of Veeva Systems from $240.00 to $272.00 and gave the company a “buy” rating in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Veeva Systems from $208.00 to $218.00 and gave the company a “neutral” rating in a research note on Monday, December 16th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and seventeen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $253.96.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.